ACON – aclarion, inc. (US:NASDAQ)

News

Aclarion Announces Agreement with Weill Cornell Medicine [Yahoo! Finance]
Aclarion Announces Agreement with Weill Cornell Medicine
Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
Aclarion (ACON) was upgraded by Wall Street Zen from "sell" to "hold"
Aclarion (ACON) had its price target lowered by Ascendiant Capital Markets from $23.00 to $7.00. They now have a "buy" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com